Home › NDC Lookup › RxCUI directory › RxCUI 209754

Caffeine 200 MG Oral Tablet [Vivarin] — RxCUI 209754

RxNorm drug concept · Semantic branded drug
RxCUI 209754 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI209754
Official nameCaffeine 200 MG Oral Tablet [Vivarin]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asVivarin 200 MG Oral Tablet
FDA products mapped2
Package NDCs mapped5
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Caffeine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Caffeine citrate is a prescription medicine given in the hospital to premature babies who have apnea of prematurity — that means they sometimes stop breathing for short periods, wh...
  • What exactly is caffeine citrate used for in babies, and is it safe?
  • The medical team will be monitoring your baby closely, but it helps to know the signs to watch for. The most serious concern is necrotizing enterocolitis (NEC) — a severe intestina...
  • What side effects should I watch for in my premature baby on caffeine citrate?
📖 Read our full Caffeine guide →

🕸️ Concept Web — How Caffeine 200 MG Oral Tablet [Vivarin] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Caffeine 200 MG Oral Tablet [Vivarin] RxCUI 209754

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Caffeine 1886
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Vivarin 220917
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Caffeine Oral Tablet 371181
    • Caffeine Oral Product 1152689
    • Caffeine Pill 1152690
    • Caffeine Oral Tablet [Vivarin] 369027
    • Vivarin Oral Product 1187402
    • Vivarin Pill 1187403
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Caffeine 200 MG Oral Tablet SCD · 198520
  • Caffeine 200 MG SCDC · 317621
  • Caffeine Oral Tablet SCDF · 371181
  • Caffeine Oral Product SCDG · 1152689
  • Caffeine Pill SCDG · 1152690

Brand-Name Concepts

  • Caffeine 200 MG [Vivarin] SBDC · 570335
  • Caffeine Oral Tablet [Vivarin] SBDF · 369027
  • Vivarin Oral Product SBDG · 1187402
  • Vivarin Pill SBDG · 1187403
  • Vivarin BN · 220917

📦 FDA Products & Package NDCs

2 products · 5 package NDCs
5 package NDCs map to RxCUI 209754 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
67751-0226-04 1 BLISTER PACK in 1 CARTON (67751-226-04) / 4 TABLET in 1 B... Vivarin Navajo Manufacturing Company Inc. 2023-06-19
71179-0018-16 2 BLISTER PACK in 1 CARTON (71179-018-16) / 8 TABLET in 1 B... VIVARIN Vespyr Brands LLC 2023-06-19
71179-0018-24 1 BOTTLE in 1 CARTON (71179-018-24) / 24 TABLET in 1 BOTTLE VIVARIN Vespyr Brands LLC 2025-09-25
71179-0018-40 5 BLISTER PACK in 1 CARTON (71179-018-40) / 8 TABLET in 1 B... VIVARIN Vespyr Brands LLC 2023-06-19
71179-0018-60 1 BOTTLE in 1 CARTON (71179-018-60) / 60 TABLET in 1 BOTTLE VIVARIN Vespyr Brands LLC 2024-01-02
Observed labelers: Vespyr Brands LLC (4) · Navajo Manufacturing Company Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.